{"id":"W4295508751","doi":"10.1038/s41587-022-01451-7","title":"Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD","year":2022,"lang":"en","type":"article","venue":"Nature Biotechnology","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Arnold Ventures; Blue Cross Blue Shield of Massachusetts","keywords":"Nebulizer; Business; COPD; Dominance (genetics); Asthma; Marketing; Brand names; Competition (biology); Advertising; Medicine; Anesthesia; Chemistry; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001832625,0.0004307478,0.0004137517,0.001041654,0.001010332,0.002014633,0.0007530036,0.002760254,0.03765432],"category_scores_gemma":[0.003605653,0.0002352156,0.001037018,0.0006839804,0.00122427,0.001425642,0.0009008929,0.002455249,0.01016788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000951955,"about_ca_system_score_gemma":0.001010183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005066007,"about_ca_topic_score_gemma":0.001249224,"domain_scores_codex":[0.9982755,0.0003132945,0.0001125308,0.0003672194,0.0007922969,0.0001390489],"domain_scores_gemma":[0.9979372,0.0005421554,0.0005601719,0.0002146987,0.0004823543,0.0002633618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002327431,0.0008928541,0.003928071,0.001978674,0.0001540634,0.001731331,0.0004790788,0.000275444,0.2528212,0.03223123,0.0823036,0.620877],"study_design_scores_gemma":[0.0002491614,0.001907623,0.01157681,0.0005398368,0.0001730864,0.004787154,0.000146539,0.0005784736,0.07126876,0.002385056,0.9063171,0.00007043495],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.2259218,0.1116142,0.02661989,0.04039489,0.01618779,0.001070045,0.006579429,0.003019935,0.5685921],"genre_scores_gemma":[0.7435114,0.02382883,0.01886528,0.02493467,0.005749642,0.0006641595,0.004049737,0.000694009,0.1777022],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03765432,"threshold_uncertainty_score":0.1259662,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008984173584401766,"score_gpt":0.2751956174091393,"score_spread":0.2662114438247375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}